# An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors

> **NCT01040312** · — · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 321 (actual)

## Conditions studied

- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Cervical Cancer
- Ovarian Cancer
- Gastric Cancer (Inoperable and Recurrent)

## Interventions

- **DRUG:** CPT-11
- **DRUG:** Platinum analogues

## Key facts

- **NCT ID:** NCT01040312
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-15
- **Primary completion:** 2014-09-29
- **Final completion:** 2015-09-02
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2019-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01040312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01040312, "An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01040312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*